Tech Company Financing Transactions

Revolution Medicines Funding Round

Revolution Medicines, based in Redwood City, scored $100 million from Boxer Capital, BVF Partners and Casdin Capital.

Transaction Overview

Announced On
7/11/2019
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series C
Investors

Boxer Capital (Lead Investor)

BVF Partners

Casdin Capital

Cormorant Asset Management

Deerfield Capital

Fidelity Management & Research Company

Nextech Invest (Thilo Schroeder)

Schroder Adveq

The Column Group (Larry Lasky)

Third Rock Ventures

Vivo Capital

Proceeds Purpose
Proceeds will support continued advancement of the company's pipeline, which includes programs addressing elusive targets within the RAS pathway such as KRASG12C(GTP) and other specific tumorigenic mutants of RAS.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
700 Saginaw Dr.
Redwood City, CA 94063
USA
Email Address
Overview
Revolution Medicines (Nasdaq: RVMD) discovers and develops important new medicines for cancer patients by translating frontier oncology targets--proteins that drive the growth of cancers or that control immune responses that can defeat them.
Profile
Revolution Medicines LinkedIn Company Profile
Social Media
Revolution Medicines Company Twitter Account
Company News
Revolution Medicines News
Facebook
Revolution Medicines on Facebook
YouTube
Revolution Medicines on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Goldsmith
  Mark Goldsmith LinkedIn Profile  Mark Goldsmith Twitter Account  Mark Goldsmith News  Mark Goldsmith on Facebook
Chief Operating Officer
Margaret Horn
  Margaret Horn LinkedIn Profile  Margaret Horn Twitter Account  Margaret Horn News  Margaret Horn on Facebook
Vice President
Adrian Gill
  Adrian Gill LinkedIn Profile  Adrian Gill Twitter Account  Adrian Gill News  Adrian Gill on Facebook
Vice President
Richard Hansen
  Richard Hansen LinkedIn Profile  Richard Hansen Twitter Account  Richard Hansen News  Richard Hansen on Facebook
Vice President
Walter Reiher
  Walter Reiher LinkedIn Profile  Walter Reiher Twitter Account  Walter Reiher News  Walter Reiher on Facebook
Vice President
Jan Smith
  Jan Smith LinkedIn Profile  Jan Smith Twitter Account  Jan Smith News  Jan Smith on Facebook
Vice President
Xiaolin Wang
  Xiaolin Wang LinkedIn Profile  Xiaolin Wang Twitter Account  Xiaolin Wang News  Xiaolin Wang on Facebook
VP - Finance
Jack Anders
  Jack Anders LinkedIn Profile  Jack Anders Twitter Account  Jack Anders News  Jack Anders on Facebook
VP - Human Resources
Luan Wilfong
  Luan Wilfong LinkedIn Profile  Luan Wilfong Twitter Account  Luan Wilfong News  Luan Wilfong on Facebook
VP - R & D
Steve Kelsey
  Steve Kelsey LinkedIn Profile  Steve Kelsey Twitter Account  Steve Kelsey News  Steve Kelsey on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/11/2019: TrustArc venture capital transaction
Next: 7/11/2019: Remitly venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary